Search

Illumina Inc

Открыт

СекторЗдравоохранение

181.31 2.77

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

173.31

Макс.

181.83

Ключевые показатели

By Trading Economics

Доход

-200M

134M

Продажи

-68M

1.1B

P/E

Средняя по отрасли

29.342

50.958

Прибыль на акцию

1.15

Рентабельность продаж

12.282

Сотрудники

8,600

EBITDA

-219M

226M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

-14.8% downside

Дивиденды

By Acuity

Следующий отчет о доходах

30 июл. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

4.9B

24B

Предыдущая цена открытия

178.54

Предыдущая цена закрытия

181.31

Новостные настроения

By Acuity

35%

65%

101 / 342 Рейтинг в Healthcare

Illumina Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

24 июн. 2026 г., 20:02 UTC

News
Social Media

Illumina Inc. shares are higher amid gains in the Life Sciences Tools & Services sector. Barclays raised its price target to $145 from $122.

23 июн. 2026 г., 22:46 UTC

Illumina Inc shares are higher in after-market trading, reflecting a notable advance since Tuesday's close and strong performance near the upper end of its one-month range.

22 июн. 2026 г., 19:32 UTC

Illumina Inc's shares are higher today, despite declines in the Nasdaq. The stock remains flat since Thursday, with no specific news driving the movement.

19 июн. 2026 г., 00:02 UTC

Correlated Moves

Illumina Inc shares are lower in after-market hours, reflecting broader market sentiment as the Russell 2000 Index also declined slightly.

18 июн. 2026 г., 23:01 UTC

Illumina Inc shares are lower in after-market hours following earlier gains. The stock showed unusual volatility during this session without identifiable news.

17 июн. 2026 г., 20:03 UTC

Correlated Moves
Macro Event

Illumina Inc shares are lower today, driven by broader market declines and macroeconomic concerns related to the Federal Reserve's monetary policy decisions.

16 июн. 2026 г., 19:56 UTC

Correlated Moves

Illumina Inc. shares are lower today, following a broader market decline. The stock remains above its 20-day moving average despite recent fluctuations.

15 июн. 2026 г., 13:02 UTC

Correlated Moves

Illumina Inc shares are higher in pre-market trading, reflecting strong momentum since Friday's close and aligning with the broader Russell 2000 Index trend.

12 июн. 2026 г., 19:56 UTC

Illumina Inc's shares are lower today, continuing a downward trend since Thursday. The stock remains above its 20-day moving average despite the decline.

11 июн. 2026 г., 20:03 UTC

Correlated Moves
News

Illumina Inc launched its StrataMap Spatial Solution, enhancing gene detection capabilities. Shares are advancing in Thursday's session, recovering from earlier lows.

10 июн. 2026 г., 23:11 UTC

Illumina Inc shares are higher in after-market trading, supported by a notable upward trend in the Life Sciences Tools & Services sub-sector.

9 июн. 2026 г., 19:26 UTC

News

Illumina shares are advancing, supported by a consensus "Hold" rating from analysts and an average price target of $138.38.

8 июн. 2026 г., 20:06 UTC

News

Illumina Inc launched the StrataMap Spatial Solution, yet shares are declining amid broader market sentiment and sector challenges.

5 июн. 2026 г., 23:16 UTC

Correlated Moves

Illumina Inc shares are roughly flat in after-market trading, reflecting broader market dynamics amid a slight decline in the Russell 2000 Index.

4 июн. 2026 г., 19:51 UTC

Illumina Inc shares are lower today, breaking a trend of higher closes since Wednesday. No specific news was identified to explain this decline.

3 июн. 2026 г., 23:03 UTC

Illumina Inc shares are higher in after-market trading, maintaining levels above its 20-day moving average amid broader market concerns about inflation and geopolitical tensions.

2 июн. 2026 г., 23:21 UTC

Correlated Moves

Illumina Inc shares declined in after-market trading, reflecting broader market trends amid mixed economic signals and a stronger-than-expected JOLTS job openings report.

1 июн. 2026 г., 23:46 UTC

Illumina Inc shares are higher in after-market trading following a report showing U.S. manufacturing activity expanded for the fifth consecutive month.

29 мая 2026 г., 20:03 UTC

Illumina Inc is higher in Friday's session, maintaining gains since Thursday's close. No specific news was identified to explain the price action.

28 мая 2026 г., 23:26 UTC

Illumina Inc shares are higher in after-market hours, reflecting routine trading activity. No specific news has been identified to explain the movement.

27 мая 2026 г., 20:02 UTC

Illumina Inc is trading higher, maintaining strong momentum and peaking during Wednesday's session, despite no specific company news identified for the movement.

21 мая 2026 г., 19:42 UTC

Illumina Inc's shares are higher during Thursday's session, recovering from an earlier dip and trading near the upper end of their one-month range.

20 мая 2026 г., 19:56 UTC

News

Illumina Inc's stock is lower after Yahoo Finance's analysis cites weak revenue growth and concerns over its business quality. Shares rebounded earlier in the session.

19 мая 2026 г., 20:03 UTC

Illumina Inc's shares are higher, supported by gains in the Life Sciences Tools & Services sub-sector, despite midday fluctuations.

18 мая 2026 г., 19:15 UTC

Correlated Moves

Illumina Inc shares are lower, continuing a four-session decline amid rising Treasury yields and broader market trends, including a drop in the Russell 2000 Index.

15 мая 2026 г., 23:56 UTC

Illumina Inc shares are lower in after-market hours, following a decline during the session amid broader market volatility and rising initial jobless claims.

14 мая 2026 г., 23:26 UTC

News

RBC Capital initiated coverage on Illumina Inc with an Outperform rating and a $170 price target. Shares are higher in after-market trading.

13 мая 2026 г., 23:21 UTC

Illumina Inc's shares are higher in after-market trading, maintaining strength above its 20-day moving average and near the top of its one-month range.

12 мая 2026 г., 23:16 UTC

Correlated Moves

Illumina Inc shares are lower in after-market trading, reflecting broader market sentiment amid rising U.S. consumer prices and inflation concerns.

Сравнение c конкурентами

Изменение цены

Illumina Inc Прогноз

Целевая цена

By TipRanks

-14.8% падение

Прогноз на 12 месяцев

Средняя 149.17 USD  -14.8%

Максимум 185 USD

Минимум 95 USD

Основано на мнении 12 аналитиков Wall Street, спрогнозировавших целевые цены для Illumina Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

12 ratings

7

Покупка

2

Удержание

3

Продажа

Настроения

By Acuity

101 / 342Рейтинг в Здравоохранение

Новостные настроения

Свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
help-icon Live chat